Ion Beam Applications SA revised earnings guidance for the year 2017. Consequently, the company will not meet its previously announced full year 2017 revenue guidance and will report a negative REBIT.

The company provided earnings guidance for the year 2018. Taking into account the strength of its equipment and service backlog, its pipeline and its cost control measures, IBA will return to a positive REBIT and net profit after tax in 2018. However due to the difficulty in predicting the timing of signature of proton therapy contracts and the impact this has on IBA's revenue recognition, IBA is withdrawing all other guidance until further notice.